Mark Schluchter Selected Research

Brachytherapy

7/2011

Adherence to vaginal dilation following high dose rate brachytherapy for endometrial cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mark Schluchter Research Topics

Disease

12	Neoplasms (Cancer) 01/2021 - 03/2006
4	Asthma (Bronchial Asthma) 05/2010 - 02/2006
3	Breast Neoplasms (Breast Cancer) 11/2018 - 10/2015
2	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 01/2009
2	Infections 12/2012 - 03/2004
2	Birth Weight (Birth Weights) 12/2006 - 07/2003
1	Stroke (Strokes) 12/2019
1	Inflammation (Inflammations) 11/2018
1	Second Primary Neoplasms (Neoplasms, Second) 01/2018
1	Obesity 11/2014
1	Parkinson Disease (Parkinson's Disease) 11/2014
1	Pain (Aches) 05/2013
1	Endometrial Neoplasms (Endometrial Cancer) 07/2011
1	Hypoxia (Hypoxemia) 07/2010
1	Pancreatic Neoplasms (Pancreatic Cancer) 09/2009
1	Disease Progression 09/2009
1	Patent Ductus Arteriosus 01/2008
1	Bronchopulmonary Dysplasia 01/2008
1	Lung Diseases (Lung Disease) 01/2007
1	Sepsis (Septicemia) 01/2007
1	Necrotizing Enterocolitis 12/2006
1	Benign Fibrous Histiocytoma (Dermatofibroma) 03/2006
1	Cognitive Dysfunction 08/2005
1	Cystic Fibrosis (Mucoviscidosis) 03/2004
1	Chronic Disease (Chronic Diseases) 07/2003

Drug/Important Bio-Agent (IBA)

3	SteroidsIBA 01/2008 - 12/2006
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 11/2018
2	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2010 - 11/2009
1	monomethyl auristatin EIBA 01/2021
1	Antimitotic AgentsIBA 01/2021
1	ProdrugsIBA 01/2021
1	AntigensIBA 01/2021
1	nitazoxanide (NTZ)FDA Link 01/2019
1	Biological FactorsIBA 11/2018
1	Interleukin-6 (Interleukin 6)IBA 11/2018
1	Dopamine (Intropin)FDA LinkGeneric 11/2014
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 12/2012
1	Cysteine (L-Cysteine)FDA Link 01/2012
1	CathepsinsIBA 01/2012
1	Albuterol (Salbutamol)FDA LinkGeneric 05/2010
1	Fluticasone (Cutivate)FDA LinkGeneric 11/2009
1	montelukast (Singulair)FDA Link 11/2009
1	Leukotriene Antagonists (Leukotriene Receptor Antagonists)IBA 11/2009
1	Cytostatic AgentsIBA 09/2009
1	Choline (Choline Chloride)IBA 01/2009
1	Photosensitizing Agents (Photosensitizers)IBA 01/2009
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2009
1	Surface-Active Agents (Surfactants)IBA 01/2008
1	Indomethacin (Indometacin)FDA LinkGeneric 01/2008
1	Oxygen (Dioxygen)IBA 01/2008
1	AllergensIBA 10/2006
1	CholesterolIBA 03/2006
1	LipidsIBA 03/2006
1	Fatty Acids (Saturated Fatty Acids)IBA 03/2004
1	Docosahexaenoic AcidsIBA 03/2004
1	Sepharose (Agarose)IBA 03/2004

Therapy/Procedure

4	Therapeutics 01/2008 - 02/2006
2	Music Therapy 10/2015 - 05/2013
1	Castration 01/2021
1	Episode of Care 12/2019
1	Resistance Training 01/2018
1	Terminal Care (Care, Terminal) 01/2017
1	Treatment Delay 11/2015
1	Time-to-Treatment 11/2015
1	Anesthesia 10/2015
1	Ear Protective Devices (Earplug) 10/2015
1	Palliative Care (Palliative Therapy) 05/2013
1	Brachytherapy 07/2011
1	Lasers (Laser) 07/2010
1	Photochemotherapy (Photodynamic Therapy) 01/2009
1	Neonatal Intensive Care 01/2008
1	Ligation 01/2008
1	Mechanical Ventilators (Ventilator) 01/2008
1	Cesarean Section (Caesarean Section) 01/2007
1	Critical Care (Surgical Intensive Care) 08/2005
1	Length of Stay 07/2003